DuoStim: Two Egg Retrievals in One Cycle
DuoStim promises to bank more eggs in less time by stimulating twice in a single menstrual cycle. The appeal is real, especially when time is short. The evidence says it mostly saves time. It doesn't clearly improve your odds of a baby.
DuoStim (double stimulation) means a first stimulation and retrieval in the follicular phase, followed almost immediately by a second stimulation and retrieval in the luteal phase of the same cycle. All eggs or embryos are frozen, and transfer happens later.
- ESHRE's 2025 ovarian stimulation guideline says double stimulation "can be used with the intention to accumulate oocytes or embryos when fresh transfer is not planned," and "can be considered for urgent fertility preservation cycles."
- Studies comparing DuoStim with two conventional cycles generally find similar egg and embryo numbers and similar live birth rates, reached faster. One 2025 study found a much shorter time to live birth (about 82 vs 154 days) with no difference in cumulative live birth rate (22.7% vs 25%).
- Critics, including an international group writing in Human Reproduction in 2023, argue that routine use in poor responders lacks rationale, evidence, and long-term follow-up, and should be studied in trials.
In this article
How DuoStim works
In a standard IVF cycle you stimulate once, in the first half of the menstrual cycle (the follicular phase), have one retrieval, and either transfer fresh or freeze. If you need more eggs, for example to build up embryos for genetic testing or because you respond poorly, you'd usually wait for another cycle and repeat.
DuoStim compresses this:
- Stimulation 1 (follicular phase): standard injections, monitoring, trigger, and retrieval.
- Stimulation 2 (luteal phase): injections restart shortly after the first retrieval, with no waiting for a period, followed by a second trigger and retrieval.
- Freeze-all: eggs or embryos from both retrievals are frozen. Transfer happens in a later cycle, often after genetic testing if that's part of the plan.
Exact timing and medications vary by clinic and by how you respond, so your protocol sheet may look different from someone else's.
Why a second stimulation is possible
The older textbook picture was one wave of follicle growth per cycle. Proponents point to research describing multiple waves of follicle recruitment within one menstrual interval. Their argument is simple: if another group of follicles is available in the luteal phase, you can stimulate it rather than let it go to waste.
The rationale explains why DuoStim is possible. Whether it produces more babies than other strategies is a separate question, and that's where the evidence is more modest.
Who it's offered to
- Poor or suboptimal responders who need several retrievals to accumulate enough eggs or embryos
- People planning PGT-A (embryo genetic testing) who want more embryos to test before any transfer
- Urgent fertility preservation, such as before cancer treatment, where there may be only a short window
- People with time pressure, whether from age, an upcoming medical treatment, or limited time off for travel
It's generally not used when you want a fresh transfer, because the second stimulation happens during the luteal phase, the window when a fresh transfer would otherwise occur.
What the evidence shows
Most published DuoStim research is observational, and much of it comes from centers that pioneered the approach. Randomized trials exist but are fewer. In their 2025 paper, Canosa and colleagues described one randomized trial comparing two stimulations in one cycle with two conventional cycles (Massin et al., 2023) as having "inconclusive results."
The 2025 study by Canosa and colleagues in the journal Life gives a useful picture of the trade-off. It compared 66 poor or suboptimal responders who had DuoStim with 46 who planned two conventional follicular-phase stimulations, all accumulating eggs for PGT-A. It was retrospective and not randomized.
| Outcome | DuoStim | Two conventional stimulations | Different? |
|---|---|---|---|
| Eggs retrieved (mean, as reported) | 8.4 | 8.2 | No |
| Euploid blastocysts (mean) | 0.9 | 1.1 | No |
| Cumulative live birth rate | 22.7% | 25% | No |
| Time to live birth (days) | 81.5 | 153.7 | Yes, shorter with DuoStim |
| Dropped out before second stimulation | 0% | 13% | Yes |
Canosa S, et al. Life 2025;15(6):899. Retrospective, single clinic, small sample.
The takeaway: in that study, DuoStim got people to the same place faster, and fewer people gave up between stimulations. It didn't get them to a better place. For someone racing a clock, faster can matter a lot. For someone who isn't, it may not be worth the extra intensity.
The skeptics' case
In 2023, the International Do No Harm Group in IVF published a commentary in Human Reproduction titled "Routine double-ovarian-stimulation (DuoStim) in poor responders lacks rationale, evidence, and follow-up." They noted that DuoStim was first proposed for fertility preservation in cancer patients and argued that, without established indications, it should be studied in controlled trials with appropriate consent rather than offered routinely.
What ESHRE's 2025 guideline says
ESHRE's updated guideline on ovarian stimulation for IVF/ICSI (2025 update) addresses double stimulation and related luteal-phase approaches directly:
- "Double stimulation can be used with the intention to accumulate oocytes or embryos when fresh transfer is not planned."
- "Double stimulation can be considered for urgent fertility preservation cycles."
- "Luteal start ovarian stimulation could be used when a fresh transfer is not intended."
- For low responders, "late luteal phase start of gonadotropins with fresh transfer is probably not recommended."
Read together: ESHRE treats DuoStim as a legitimate tool for accumulating eggs or embryos when you're freezing everything anyway. It doesn't present it as a way to improve live birth chances in poor responders.
Trade-offs: time, cost, and two procedures
| Possible advantages | Possible downsides |
|---|---|
| Reaches a target number of eggs or embryos sooner | Two retrievals close together, each with procedure and sedation risks |
| Fewer chances to drop out between cycles | Continuous injections and monitoring for several weeks |
| Useful when a medical deadline is fixed | No fresh transfer; everything is frozen |
| May reduce travel or time off work | Medication and lab costs are roughly those of two stimulations; pricing varies widely |
| Limited long-term data, as critics point out |
On cost, ask how the clinic prices it: as one package, as two cycles, or as a cycle plus an add-on. Get the full itemized estimate before you agree, including freezing, storage, and genetic testing if relevant.
For many poor responders, DuoStim sits next to other strategies with their own evidence profiles. Our guide to growth hormone for poor responders covers an adjuvant that's often offered at the same point. If someone is offering ovarian PRP, know that it's experimental.
Signs it may not be the right fit
DuoStim tends to make the least sense when the main advantage, speed, doesn't matter much to you. That might be the case if:
- You'd prefer a fresh transfer and have no reason to freeze everything.
- You respond well to stimulation and one retrieval is likely to give you enough embryos.
- The physical or emotional load of back-to-back stimulations would be hard right now. Several weeks of near-continuous injections, scans, and two procedures is a lot, and it's fine to say so.
- The added cost would stop you from affording a later transfer or another cycle.
It's also reasonable to treat the decision as staged. Ask whether the plan can be reviewed after the first retrieval, so the second stimulation goes ahead only if it still makes sense given how you responded.
DuoStim and traveling for treatment
If you're traveling for IVF, DuoStim can mean one longer trip instead of two separate ones. That's a real practical advantage. It's also a reason to be careful, because convenience alone shouldn't decide a medical protocol. If cost or logistics are pushing you to look abroad, colombianivf.com is a resource for people considering IVF in Colombia. Ask any clinic you consider how often it uses DuoStim, for which patients, and what its own outcomes look like compared with conventional cycles.
If you'll freeze embryos abroad and transfer at home later, read our guide to shipping embryos internationally before you start.
Questions to ask before choosing it
- What's the goal: a specific number of eggs, embryos, or euploid embryos? How many retrievals do you expect that to take?
- Why DuoStim for me rather than two conventional cycles? Is the benefit time, or do you expect better odds?
- How many DuoStim cycles does your clinic do, and what are your outcomes compared with conventional cycles?
- What's the full cost, itemized, and is it priced as one cycle or two?
- What happens if the first stimulation goes very well, or very poorly? Can we skip the second?
- When would a frozen transfer realistically happen?
Frequently asked questions
Does DuoStim improve the chance of having a baby?
Current evidence suggests it mainly saves time. A 2025 study of poor and suboptimal responders found similar egg numbers, euploid embryos, and cumulative live birth rates compared with two conventional stimulations, but a much shorter time to live birth.
Is DuoStim recommended by guidelines?
ESHRE's 2025 ovarian stimulation guideline says double stimulation can be used to accumulate eggs or embryos when a fresh transfer is not planned and can be considered for urgent fertility preservation. It does not present it as a way to improve live birth rates in poor responders.
Can I do a fresh transfer with DuoStim?
Generally no. The second stimulation happens during the luteal phase, so eggs or embryos from both retrievals are frozen and transferred in a later cycle.
Who is DuoStim best suited for?
People who need to accumulate eggs or embryos quickly, such as poor responders planning several retrievals, those doing embryo genetic testing, and people preserving fertility before cancer treatment or other time-sensitive situations.
Why do some experts criticize DuoStim?
An international group writing in Human Reproduction in 2023 argued that routine use in poor responders lacks rationale, evidence, and long-term follow-up, and proposed that it be studied within controlled trials until clear indications are established.
Sources
- ESHRE. Guideline on ovarian stimulation for IVF/ICSI, 2025 update (guideline PDF). https://www.eshre.eu/-/media/sitecore-files/Guidelines/COS/2025/ESHRE-OS-guideline-updateSept-2026v23.pdf
- ESHRE. Ovarian stimulation guideline landing page. https://www.eshre.eu/OSguide
- Canosa S, et al. DuoStim shows comparable efficacy but better efficiency than two conventional stimulations in poor/suboptimal responders undergoing vitrified oocyte accumulation for PGT-A. Life. 2025;15(6):899. https://www.mdpi.com/2075-1729/15/6/899/htm
- International Do No Harm Group in IVF. Routine double-ovarian-stimulation (DuoStim) in poor responders lacks rationale, evidence, and follow-up. Hum Reprod. 2023;38(3):329-333. https://scholars.mssm.edu/en/publications/routine-double-ovarian-stimulation-duostim-in-poor-responders-lac/
Medical disclaimer: This article is general education, not medical advice, and it cannot account for your history, test results, or treatment plan. Please make medication and treatment decisions with your own fertility team, and never start, stop, or change a prescribed medication without talking to the prescriber.
If you have severe abdominal pain, heavy bleeding, fainting, or shoulder-tip pain during or after fertility treatment, seek urgent care.